- Zebrafish Cardiovascular Disease Models
- Zebrafish Duchenne Muscular Dystrophia Models
- Zebrafish IBD Models
- Zebrafish Inflammatory Disease Models
- Zebrafish Kidney Disease Models
- Zebrafish Neurological Disorder Models
- Zebrafish Skeletal Disease Models
- Zebrafish Ocular Disease Models
- Zebrafish Hematological Disease Models
- Zebrafish Liver Disease Models
- Zebrafish Tumor Models
- Zebrafish Hearing-Related Disease Models
- Zebrafish Regeneration Models
- Zebrafish Cardiotoxicity Assays
- Zebrafish Developmental and Reproductive Toxicity
- Zebrafish Developmental Neurotoxicity Assays
- Zebrafish EcoToxicity Assays
- Zebrafish Hepatoxicity Assays
- Zebrafish Immunotoxicology Assays
- Zebrafish Nephrotoxicity Assays
- Zebrafish Ocular Toxicity
- Zebrafish Ototoxicity Assays
- Zebrafish Vascular Toxicity
Zebrafish Hematological Disease Models
Hematopoiesis is a complex process with various signaling pathways influencing every step of blood cell formation from the earliest precursors to final differentiated blood cell types. The formation of blood cells is vital for survival. Hematopoietic Stem and Progenitor Cells (HSPCs) are responsible for creating all adult differentiated blood cells. Genes that are mutated in hematopoietic malignancies and disease are often required for the normal maintenance and production of blood cells not only in adult tissues but also in the developing embryo. Defects in HSPCs or their downstream lineages can result in anemia and other hematological disorders including leukemia. Thus, understanding the molecular and cellular mechanisms that drive normal hematopoiesis and hematopoietic malignancies is critical for developing new treatments for blood diseases.
Zebrafish are being increasingly used as a model organism to investigate vertebrate hematopoiesis. This genetically tractable model has a number of appealing features, such as the ease of manipulation of transparent embryos and the capacity to conduct large-scale genetic and chemical screens. Zebrafish shares, with other vertebrates, all major blood cell types that are generated by similar developmental pathways. Besides, many of the genes known to regulate erythropoiesis in mammals have been identified in zebrafish. There is also a high conservation of transcription factors and major signaling pathways involved in hematopoietic stem cell (HSC) maturation and differentiation. As in mammals, zebrafish blood development contains three sequential waves: the primitive one, the erythromyeloid progenitor (EPM-derived) wave and the definitive wave that occurs in different embryonic locations. Thus, the parallels between the hematopoietic system in zebrafish and humans prompt the increasing use of zebrafish to model hematological disorders.
Figure 1. Zebrafish hematopoiesis and its key regulators. (Rasighaemi P, et al. 2015)
Zebrafish Models of Hematological Disease
Creative Biogene, a zebrafish preclinical contract research organization, has modelled a significant number of human hematopoietic malignancies in zebrafish by genome editing technologies such as TALENs and CRISPR/Cas9 systems. The models were developed by generating stable transgenic lines or through transient overexpression of human or zebrafish orthologs of oncogenes associated with hematopoietic malignancies. In addition, we can also use cell-type specific promoters to drive the expression of human oncogenes and fusion gene cDNAs in zebrafish.
|Human Disease Condition||Zebrafish Transgenic Line||Affected Gene|
|Hereditary elliptocytosis||chablis and merlot||epb41b|
|Hereditary spherocytosis type 2||riesling||b-spectrin|
|Hereditary spherocytosis type 4||retsina||slc4a1|
|Erythropoietic protoporphyria and X-linked sideroblastic anemia||sauternes||alas2|
|Hypochromic microcytic anemia||zinfandel||hbbe1.1|
|Hypochromic microcytic anemia||chianti||tfr1a|
|Hemochromatosis type 4||weissherbst||slc40a1|
|Acute myeloid leukemia||Tg(hsp:AML1-ETO)||runx1|
|Acute myeloid leukemia||Tg(spi1:lox-EGFP-loxNUP98-HOXA9)||hoxa9|
|Myelodysplastic syndrome||Tet2 mutants||Tet2|
|T-cell acute lymphoblastic leukemia||Tg(rag2:EGFP-myc)||Myc-oncogene overexpression|
|T-cell acute lymphoblastic leukemia||Tg(rag2:NOTCH1ICD-EGFP)||Notch1-intracellular domain overexpression|
|Pre-B cell acute lymphoblastic leukemia||Tg(ef1alpha:EGFP-TELAML1)||runx1|
- Small size, high fecundity, and fast embryonic development make zebrafish suitable for large-scale forward and modifier genetic screens.
- Phenotype-based screens provide unbiased identification of candidate genetic pathways.
- Zebrafish blood disease models have the potential to reveal new drugs for human disease treatment.
- The transparency of zebrafish embryos allows live imaging of hematopoietic cells and of the pathologies of the diseases that affect them.
With extensive experience in zebrafish research, our scientists can help you choose the right model and experimental design to achieve your research and development goals.
- Zizioli D, et al. Zebrafish disease models in hematology: highlights on biological and translational impact. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease, 2019, 1865(3): 620-633.
- Rissone A, Burgess S M. Rare genetic blood disease modeling in zebrafish. Frontiers in genetics, 2018, 9: 348.
- Gore A V, et al. The zebrafish: A fintastic model for hematopoietic development and disease. Wiley Interdisciplinary Reviews: Developmental Biology, 2018, 7(3): e312.
- Jing L, Zon L I. Zebrafish as a model for normal and malignant hematopoiesis. Disease models & mechanisms, 2011, 4(4): 433-438.
- Rasighaemi P, et al. Zebrafish as a model for leukemia and other hematopoietic disorders. Journal of hematology & oncology, 2015, 8(1): 1-10.
For research use only. Not intended for any clinical use.